Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5899537 | Diabetes Research and Clinical Practice | 2014 | 6 Pages |
Abstract
We conducted a meta-analysis to compare the efficacy and safety of repaglinide plus metformin with metformin alone on type 2 diabetes. Twenty-two studies were included in this meta-analysis. Results showed combination therapy was safe and could gain better outcomes in glycemic control. Well-designed studies are required to confirm this conclusion.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Jinjin Yin, Houliang Deng, Shumin Qin, Waijiao Tang, Lu Zeng, Benjie Zhou,